Skip to content
OpenCapital
Get started

Johnson & Johnson JNJ MEDTECH — Cost of products sold

Other segment segments

Innovative Medicine
$4.39B+9.2%

Similar metrics at other companies

AngioDynamics logo
ANGOMed Tech — Gross Profit
$23.29M+18.9%
AngioDynamics logo
ANGOMed Tech — Cost of sales (exclusive of intangible amortization)
$13.99M+19.0%
AngioDynamics logo
ANGOMed Tech — Net Sales
$37.28M+19.0%
Knowles logo
KNMedTech & Specialty Audio — Adjusted Cost of Goods Sold
$31.6M+3.3%
Artivion logo
AORTMedical devices — Total gross margin
$61.75M+15.3%
AngioDynamics logo
ANGOMed Device — Gross Profit
$18.19M-5.6%

Other financials

Income statement

See full
Revenue$24.1B+9.9%
Gross profit$16.0B+9.8%
Operating income$6.3B+2.3%
Net income$5.2B-52.4%
EPS (diluted)$2.14-52.9%

Balance sheet

See full
Cash & equivalents$21.7B-43.6%
Total debt$55.0B+5.2%
Total equity$81.2B+3.9%
Total assets$200.89B+3.7%

Cash flow

See full
Operating cash flow$2.5B-39.8%
CapEx$1.0B+31.9%
Free cash flow$1.5B-56.6%

Valuation

See full
Market cap$623.71B+66.9%
Enterprise value$657.01B+61.9%
P/E29.6×+13.2×
P/S6.5×+2.3×

Profitability

See full
Gross margin67.8%-0.5pp
Operating margin26.4%+2.8pp
Net margin21.8%-2.6pp
FCF margin18.5%-4.3pp

Returns & leverage

See full
Return on equity26.4%-3.0pp
Debt / equity0.7×0.0×
Current ratio1×-0.2×

Where this comes from

Reported directly by Johnson & Johnson in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The official record: Johnson & Johnson’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Johnson & Johnson's medtech — cost of products sold.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Johnson & Johnson's MEDTECH — cost of products sold?
Johnson & Johnson (JNJ) reported MEDTECH — cost of products sold of $3.7B in Q1 2026.
How has Johnson & Johnson's MEDTECH — cost of products sold changed year-over-year?
Johnson & Johnson's MEDTECH — cost of products sold increased by 11.3% year-over-year, from $3.33B to $3.7B.
What is the long-term trend for Johnson & Johnson's MEDTECH — cost of products sold?
Over 3 years (2022 to 2025), Johnson & Johnson's MEDTECH — cost of products sold has grown at a 11.9% compound annual growth rate (CAGR), from $10.4B to $14.55B.
What does MEDTECH — cost of products sold mean?
Includes the direct costs associated with manufacturing, sourcing, and distributing medical devices sold by the segment. This metric is essential for calculating the gross margin and assessing the operational efficiency of the MedTech supply chain.